Plus   Neg

Big Yellow Completes 7-year Debt Facility With Aviva

Big Yellow Group Plc. (BYG.L) said that it has completed a 7 year debt facility with Aviva of 35 million pounds at an all-in cost of 1.96%, secured over the existing Aviva security pool of 15 stores. The all-in cost reduces to 1.91% following the installation of 50 kWh capacity solar panels at three of the stores.

The company noted that the total debt facilities from Aviva are now 117.5 million pounds of which 82.5 million pounds will continue to amortise down to 60 million pounds over the remaining seven years of the loan.

The new facility provides the Group with headroom of cash and undrawn bank facilities of 73 million pounds.

The average cost of debt on drawn facilities is now 2.6% and the marginal cost of RCF bank debt remains at 1.35%

The Group's earliest maturity is on its 70 million pounds M&G loan in June 2023 and the Group's debt has an average maturity of 4.9 years.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
Follow RTT